家庭-社区-医院三级联动护理在慢性乙型肝炎患者中的应用

Application of family-community-hospital linked care in patients with chronic hepatitis B

  • 摘要:
    目的 探讨家庭-社区-医院三级联动护理在慢性乙型肝炎患者中的应用效果。
    方法 选取118例慢性乙型肝炎患者为研究对象,使用随机数字表法分为对照组和观察组,每组59例。对照组采取常规健康教育,观察组在对照组基础上实施家庭-社区-医院三级联动护理。比较2组患者干预前、干预2个月后社会支持、治疗依从性、生活质量、恐惧心理差异。
    结果 干预2个月后, 2组患者社会支持评定量表(SSRS)、慢性乙型肝炎患者治疗依从性量表、慢性肝病问卷(CLDQ)得分均较干预前上升,且观察组患者SSRS、慢性乙型肝炎患者治疗依从性量表、CLDQ得分均高于对照组,差异有统计学意义(P < 0.05); 2组患者恐惧疾病进展简化量表(FoP-Q-SF)的社会家庭、生理健康得分均较干预前下降,且观察组低于对照组,差异有统计学意义(P < 0.05)。
    结论 家庭-社区-医院三级联动护理有助于慢性乙型肝炎患者社会支持、治疗依从性、生活质量的提升,能减轻患者对疾病的恐惧。

     

    Abstract:
    Objective To explore the application effect of family-community-hospital linked care in patients with chronic hepatitis B.
    Methods A total of 118 patients with chronic hepatitis B were selected and randomly divided into control group and observation group using a random number table method, with 59 patients in each group. The control group received routine health education, while the observation group received family-community-hospital ternary linked care on the basis of the control group received family-community-hospital linked care. The social support, treatment adherence, quality of life, and fear of disease progression between the two groups were compared before intervention and 2 months after the intervention.
    Results Two months after the intervention, the scores of the Social Support Rating Scale (SSRS), the Treatment Adherence Scale for chronic hepatitis B patients, and the Chronic Liver Disease Questionnaire (CLDQ) increased in both groups compared with those before the intervention, and the above scores were higher in the observation group than in those in the control group (P < 0.05). The scores of social family and physical health on the Fear of Progression Questionnaire-Short Form (FoP-Q-SF) decreased in both groups compared with those before the intervention, and the scores were lower in the observation group than those in the control group (P < 0.05).
    Conclusion Family-community-hospital linked care can improve social support, treatment adherence, and quality of life in patients with chronic hepatitis B and alleviate their fear of the disease.

     

/

返回文章
返回